No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
68 |
4. Check minimum number of eventsNone |
68 |
5. Include endpointsNone |
68 |
6. Filter based on genotype QC (FinnGen only) |
66 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Similar endpoints
↥List of similar endpoints to
Microtia (small ears)
based on the number of shared cases.
Similar with more cases:
- Other congenital malformations of ear
- Congenital malformations of eye, ear, face and neck
- Congenital malformations, deformations and chromosomal abnormalities
- Congenital malformations, deformations and chromosomal abnormalities
- Any operation in hilmo
Similar with less cases:
None
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: unknown.
No upset table: unknown.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 66 | 42 | 24 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 16.99 | 18.08 | 15.08 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 68
- Matched controls
- 680
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q172, ,
ICD-10 Finland
Microtia
+∞
97.7
68
*
A98, ,
ICD-O-3
+∞
94.8
67
*
J01CA04, ,
ATC
amoxicillin; systemic
+∞
87.7
64
*
M01AE01, ,
ATC
ibuprofen; systemic, rectal
+∞
75.9
58
*
WX110, ,
ICD-O-3
+∞
67.2
53
*
SAA02, ,
ICD-O-3
+∞
67.2
53
*
J01DB01, ,
ATC
cefalexin; oral
+∞
65.6
52
*
N02BE01, ,
ATC
paracetamol; systemic, rectal
+∞
64.0
51
*
J01CE02, ,
ATC
phenoxymethylpenicillin; oral
+∞
54.8
45
*
SAA01, ,
ICD-O-3
+∞
54.8
45
*
ZXD10, ,
ICD-O-3
+∞
50.4
42
*
J01FA10, ,
ATC
azithromycin; systemic
+∞
49.0
41
*
K021, ,
ICD-O-3
+∞
47.6
40
*
ZXE00, ,
ICD-O-3
+∞
46.2
39
*
ZXE10, ,
ICD-O-3
+∞
43.5
37
*
EB1SA, ,
ICD-O-3
+∞
43.5
37
*
J01CR02, ,
ATC
amoxicillin and beta-lactamase inhibitor; systemic
+∞
43.5
37
*
WX290, ,
ICD-O-3
+∞
42.1
36
*
SFA20, ,
ICD-O-3
+∞
42.1
36
*
SAA03, ,
ICD-O-3
+∞
42.1
36
*
SFA10, ,
ICD-O-3
+∞
42.1
36
*
J069, ,
ICD-O-3
+∞
40.8
35
*
Z012, ,
ICD-O-3
+∞
40.8
35
*
WYA05, ,
ICD-O-3
+∞
39.5
34
*
M01AE02, ,
ATC
naproxen; oral, rectal
+∞
39.5
34
*
EB1HA, ,
ICD-O-3
+∞
38.1
33
*
EB1AA, ,
ICD-O-3
+∞
36.8
32
*
J01DA01, ,
ATC
[U] cefalexin
+∞
35.6
31
*
WX408, ,
ICD-O-3
+∞
35.6
31
*
M03BX02, ,
ATC
tizanidine; oral
+∞
34.3
30
*
SCA01, ,
ICD-O-3
+∞
33.0
29
*
WZC00, ,
ICD-O-3
+∞
31.8
28
*
R74, ,
ICD-O-3
+∞
31.8
28
*
-1, ,
ICD-O-3
+∞
31.8
28
*
EBA00, ,
ICD-O-3
+∞
30.5
27
*
Z011, ,
ICD-10 Finland
Examination of ears and hearing
+∞
30.5
27
*
M01AB05, ,
ATC
diclofenac; systemic, rectal
+∞
30.5
27
*
R06AE07, ,
ATC
cetirizine; oral
+∞
29.3
26
*
R03AC02, ,
ATC
salbutamol; inhalant
+∞
29.3
26
*
ZXA00, ,
ICD-O-3
+∞
29.3
26
*
KMAK, ,
ICD-O-3
+∞
28.1
25
*
WX404, ,
ICD-O-3
+∞
28.1
25
*
R21, ,
ICD-O-3
+∞
28.1
25
*
E0000UV, ,
ATC
+∞
26.8
24
*
SDA02, ,
ICD-O-3
+∞
26.8
24
*
K0364, ,
ICD-O-3
+∞
25.6
23
*
SDA03, ,
ICD-O-3
+∞
25.6
23
*
Z2221, ,
ICD-O-3
+∞
25.6
23
*
D82, ,
ICD-O-3
+∞
25.6
23
*
A02BC02, ,
ATC
pantoprazole; systemic
+∞
25.6
23
*
GD1AA, ,
ICD-O-3
+∞
25.6
23
*
SPAT1263, ,
ICD-O-3
+∞
25.6
23
*
S18, ,
ICD-O-3
+∞
24.4
22
*
J01EE02, ,
ATC
sulfadiazine and trimethoprim; systemic
+∞
24.4
22
*
ZXE20, ,
ICD-O-3
+∞
24.4
22
*
SDA01, ,
ICD-O-3
+∞
24.4
22
*
DAD10, ,
ICD-O-3
+∞
23.2
21
*
Q160, ,
ICD-10 Finland
Congenital absence of (ear) auricle
+∞
23.2
21
*
N02AJ06, ,
ATC
codeine and paracetamol; systemic
+∞
23.2
21
*
ZXA10, ,
ICD-O-3
+∞
23.2
21
*
SPAT1315, ,
ICD-O-3
+∞
23.2
21
*
D19, ,
ICD-O-3
+∞
23.2
21
*
Z3231, ,
ICD-O-3
+∞
23.2
21
*
R4110, ,
ICD-O-3
+∞
22.1
20
*
H901, ,
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
+∞
22.1
20
*
WX402, ,
ICD-O-3
+∞
22.1
20
*
DFF00, ,
ICD-O-3
+∞
22.1
20
*
J01AA02, ,
ATC
doxycycline; systemic
+∞
22.1
20
*
Z718, ,
ICD-10 Finland
Other specified counselling
+∞
22.1
20
*
Q161, ,
ICD-10 Finland
Congenital absence, atresia and stricture of auditory canal (external)
+∞
22.1
20
*
R06AX27, ,
ATC
desloratadine; oral
+∞
22.1
20
*
R5110, ,
ICD-O-3
+∞
20.9
19
*
R83, ,
ICD-O-3
+∞
20.9
19
*
M01AH05, ,
ATC
etoricoxib; oral
+∞
20.9
19
*
R05, ,
ICD-O-3
+∞
20.9
19
*
OAB43, ,
ICD-O-3
+∞
20.9
19
*
WZA90, ,
ICD-O-3
+∞
20.9
19
*
WZB00, ,
ICD-O-3
+∞
20.9
19
*
SPAT1312, ,
ICD-O-3
+∞
20.9
19
*
Z018, ,
ICD-10 Finland
Other specified special examinations
+∞
19.7
18
*
SPAT1253, ,
ICD-O-3
+∞
19.7
18
*
ZXA05, ,
ICD-O-3
+∞
19.7
18
*
R01AD09, ,
ATC
mometasone; nasal
+∞
19.7
18
*
SBB10, ,
ICD-O-3
+∞
19.7
18
*
Z3229, ,
ICD-O-3
+∞
19.7
18
*
D07AB02, ,
ATC
hydrocortisone butyrate; topical
+∞
18.6
17
*
SPAT1283, ,
ICD-O-3
+∞
18.6
17
*
J01FF01, ,
ATC
clindamycin; systemic
+∞
18.6
17
*
M545, ,
ICD-O-3
+∞
18.6
17
*
H903, ,
ICD-10 Finland
Sensorineural hearing loss, bilateral
+∞
18.6
17
*
SPAT1325, ,
ICD-O-3
+∞
18.6
17
*
SPAT1256, ,
ICD-O-3
+∞
18.6
17
*
DAX00, ,
ICD-O-3
+∞
17.4
16
*
L03, ,
ICD-O-3
+∞
17.4
16
*
R01AD12, ,
ATC
fluticasone furoate; nasal
+∞
17.4
16
*
J02AC01, ,
ATC
fluconazole; systemic
+∞
17.4
16
*
N06AX11, ,
ATC
mirtazapine; oral
+∞
17.4
16
*
Z3226, ,
ICD-O-3
+∞
17.4
16
*
Z718, ,
ICD-O-3
+∞
17.4
16
*
J01MA02, ,
ATC
ciprofloxacin; systemic
+∞
17.4
16
*
M01AE03, ,
ATC
ketoprofen; systemic, rectal
+∞
16.3
15
*
K020, ,
ICD-O-3
+∞
16.3
15
*
R05FA02, ,
ATC
opium derivatives and expectorants; systemic
+∞
16.3
15
*
SPAT1249, ,
ICD-O-3
+∞
16.3
15
*
H02AB06, ,
ATC
prednisolone; systemic
+∞
16.3
15
*
EBA10, ,
ICD-O-3
+∞
16.3
15
*
Z871, ,
ICD-O-3
+∞
16.3
15
*
N02AX02, ,
ATC
tramadol; systemic, rectal
+∞
16.3
15
*
R104, ,
ICD-10 Finland
Other and unspecified abdominal pain
+∞
16.3
15
*
M54, ,
ICD-O-3
+∞
16.3
15
*
VALMI, ,
ICD-O-3
+∞
16.3
15
*
N02AA59, ,
ATC
codeine, combinations excl. psycholeptics; systemic
+∞
16.3
15
*
SPAT1310, ,
ICD-O-3
+∞
15.2
14
*
WX002, ,
ICD-O-3
+∞
15.2
14
*
U072, ,
ICD-O-3
+∞
15.2
14
*
N01, ,
ICD-O-3
+∞
15.2
14
*
SPAT1363, ,
ICD-O-3
+∞
15.2
14
*
R05FB02, ,
ATC
cough suppressants and expectorants; systemic
+∞
15.2
14
*
R104, ,
ICD-O-3
+∞
15.2
14
*
J01DA09, ,
ATC
[U] cefadroxil
+∞
15.2
14
*
H900, ,
ICD-10 Finland
Conductive hearing loss, bilateral
+∞
15.2
14
*
J01FA09, ,
ATC
clarithromycin; systemic
+∞
15.2
14
*
N05BA04, ,
ATC
oxazepam; oral
+∞
15.2
14
*
UJD10, ,
ICD-O-3
+∞
15.2
14
*
L17, ,
ICD-O-3
+∞
15.2
14
*
R01AD08, ,
ATC
fluticasone; nasal
+∞
15.2
14
*
J069, ,
ICD-10 Finland
Acute upper respiratory infection, unspecified
+∞
15.2
14
*
J01CA08, ,
ATC
pivmecillinam; oral
+∞
15.2
14
*
ZZG00, ,
ICD-O-3
+∞
15.2
14
*
GD1UA, ,
ICD-O-3
+∞
15.2
14
*
Z760, ,
ICD-O-3
+∞
14.0
13
*
UDC00, ,
ICD-O-3
+∞
14.0
13
*
Z363, ,
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
+∞
14.0
13
*
J01DA08, ,
ATC
[U] cefaclor
+∞
14.0
13
*
ZXD05, ,
ICD-O-3
+∞
14.0
13
*
I10, ,
ICD-O-3
+∞
14.0
13
*
SDA04, ,
ICD-O-3
+∞
14.0
13
*
TPH04, ,
ICD-O-3
+∞
14.0
13
*
WW200, ,
ICD-O-3
+∞
14.0
13
*
J209, ,
ICD-O-3
+∞
14.0
13
*
R5140, ,
ICD-O-3
+∞
14.0
13
*
SFC01, ,
ICD-O-3
+∞
12.9
12
*
W11, ,
ICD-O-3
+∞
12.9
12
*
SPAT1317, ,
ICD-O-3
+∞
12.9
12
*
SDE02, ,
ICD-O-3
+∞
12.9
12
*
SPAT1153, ,
ICD-O-3
+∞
12.9
12
*
SFA30, ,
ICD-O-3
+∞
12.9
12
*
M796, ,
ICD-O-3
+∞
12.9
12
*
M255, ,
ICD-O-3
+∞
12.9
12
*
D07AA02, ,
ATC
hydrocortisone; topical
+∞
12.9
12
*
SPAT1316, ,
ICD-O-3
+∞
12.9
12
*
A02BC05, ,
ATC
esomeprazole; systemic
+∞
12.9
12
*
N06AB10, ,
ATC
escitalopram; oral
+∞
12.9
12
*
S29, ,
ICD-O-3
+∞
12.9
12
*
L12, ,
ICD-O-3
+∞
11.8
11
*
SPAT1301, ,
ICD-O-3
+∞
11.8
11
*
SPAT1308, ,
ICD-O-3
+∞
11.8
11
*
SXC05, ,
ICD-O-3
+∞
11.8
11
*
Z001, ,
ICD-O-3
+∞
11.8
11
*
SBB00, ,
ICD-O-3
+∞
11.8
11
*
JN3AE, ,
ICD-O-3
+∞
11.8
11
*
Z010, ,
ICD-10 Finland
Examination of eyes and vision
+∞
11.8
11
*
D07AC01, ,
ATC
betamethasone; topical
+∞
11.8
11
*
L01, ,
ICD-O-3
+∞
11.8
11
*
R01AD58, ,
ATC
fluticasone, combinations; nasal
+∞
11.8
11
*
R05DA20, ,
ATC
opium alkaloids and derivatives - combinations
+∞
11.8
11
*
X59, ,
ICD-10 Finland
Exposure to unspecified factor
+∞
11.8
11
*
Z301, ,
ICD-O-3
+∞
11.8
11
*
DC1AD, ,
ICD-O-3
+∞
11.8
11
*
N06AB03, ,
ATC
fluoxetine; oral
+∞
11.8
11
*
ZYC01, ,
ICD-O-3
+∞
11.8
11
*
ZZA00, ,
ICD-O-3
+∞
11.8
11
*
Z2446, ,
ICD-O-3
+∞
11.8
11
*
A97, ,
ICD-O-3
+∞
11.8
11
*
UJF32, ,
ICD-O-3
+∞
10.7
10
*
N05CF01, ,
ATC
zopiclone; oral
+∞
10.7
10
*
K0365, ,
ICD-O-3
+∞
10.7
10
*
A03, ,
ICD-O-3
+∞
10.7
10
*
A04, ,
ICD-O-3
+∞
10.7
10
*
J01EA01, ,
ATC
trimethoprim; systemic
+∞
10.7
10
*
ZXE30, ,
ICD-O-3
+∞
10.7
10
*
D01, ,
ICD-O-3
+∞
10.7
10
*
EB1MA, ,
ICD-O-3
+∞
10.7
10
*
DEE00, ,
ICD-O-3
+∞
10.7
10
*
S01XA20, ,
ATC
artificial tears and other indifferent preparations; ophthalmic
+∞
10.7
10
*
SPAT1223, ,
ICD-O-3
+∞
10.7
10
*
I10, ,
ICD-10 Finland
Essential (primary) hypertension
+∞
10.7
10
*
SAA04, ,
ICD-O-3
+∞
10.7
10
*
EBA05, ,
ICD-O-3
+∞
10.7
10
*
C07AA05, ,
ATC
propranolol; systemic
+∞
10.7
10
*
H669, ,
ICD-10 Finland
Otitis media, unspecified
+∞
10.7
10
*
F29, ,
ICD-O-3
+∞
10.7
10
*
G473, ,
ICD-10 Finland
Sleep apnoea
+∞
10.7
10
*
FM1AE, ,
ICD-O-3
+∞
10.7
10
*
Z712, ,
ICD-O-3
+∞
10.7
10
*
XF400, ,
ICD-O-3
+∞
10.7
10
*
K0510, ,
ICD-O-3
+∞
10.7
10
*
W78, ,
ICD-O-3
+∞
10.7
10
*
LC2BE, ,
ICD-O-3
+∞
10.7
10
*
QA4S1, ,
ICD-O-3
+∞
10.7
10
*
Z039, ,
ICD-10 Finland
Observation for suspected disease or condition, unspecified
+∞
9.6
9
*
P01AB01, ,
ATC
metronidazole; oral, rectal
+∞
9.6
9
*
WX602, ,
ICD-O-3
+∞
9.6
9
*
WYA30, ,
ICD-O-3
+∞
9.6
9
*
P03, ,
ICD-O-3
+∞
9.6
9
*
R03CC02, ,
ATC
salbutamol; systemic
+∞
9.6
9
*
DAD30, ,
ICD-O-3
+∞
9.6
9
*
SAD01, ,
ICD-O-3
+∞
9.6
9
*
R01BA51, ,
ATC
phenylpropanolamine, combinations; oral
+∞
9.6
9
*
Z2445, ,
ICD-O-3
+∞
9.6
9
*
A10BA02, ,
ATC
metformin; oral
+∞
9.6
9
*
SJD10, ,
ICD-O-3
+∞
9.6
9
*
SJC50, ,
ICD-O-3
+∞
9.6
9
*
R03BA02, ,
ATC
budesonide; inhalant
+∞
9.6
9
*
Z000, ,
ICD-O-3
+∞
9.6
9
*
MA2AE, ,
ICD-O-3
+∞
9.6
9
*
SDE03, ,
ICD-O-3
+∞
9.6
9
*
OAA65, ,
ICD-O-3
+∞
9.6
9
*
Z048, ,
ICD-10 Finland
Examination and observation for other specified reasons
+∞
9.6
9
*
H660, ,
ICD-10 Finland
Acute suppurative otitis media
+∞
9.6
9
*
D07BA04, ,
ATC
hydrocortisone and antiseptics; topical
+∞
9.6
9
*
Z113, ,
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
+∞
9.6
9
*
DCA20, ,
ICD-O-3
+∞
9.6
9
*
J189, ,
ICD-10 Finland
Pneumonia, unspecified
+∞
9.6
9
*
M03BC51, ,
ATC
orphenadrine, combinations; systemic
+∞
9.6
9
*
E000001, ,
ATC
+∞
9.6
9
*
W01, ,
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
+∞
9.6
9
*
R5130, ,
ICD-O-3
+∞
9.6
9
*
N05AH04, ,
ATC
quetiapine; oral
+∞
9.6
9
*
J01FA01, ,
ATC
erythromycin; systemic
+∞
9.6
9
*
SJD00, ,
ICD-O-3
+∞
9.6
9
*
EMB30, ,
ICD-O-3
+∞
9.6
9
*
P01, ,
ICD-O-3
+∞
9.6
9
*
SPAT1254, ,
ICD-O-3
+∞
9.6
9
*
EB4VA, ,
ICD-O-3
+∞
9.6
9
*
FM1EE, ,
ICD-O-3
+∞
9.6
9
*
M03BC01, ,
ATC
orphenadrine (citrate); systemic
+∞
9.6
9
*
S01GX01, ,
ATC
cromoglicic acid; ophthalmic
+∞
8.5
8
*
A09, ,
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
+∞
8.5
8
*
SJB00, ,
ICD-O-3
+∞
8.5
8
*
U071, ,
ICD-O-3
+∞
8.5
8
*
R509, ,
ICD-10 Finland
Fever, unspecified
+∞
8.5
8
*
SDE04, ,
ICD-O-3
+∞
8.5
8
*
SGC10, ,
ICD-O-3
+∞
8.5
8
*
P29, ,
ICD-O-3
+∞
8.5
8
*
215, ,
Kela drug reimbursment
Diabetes, non-insulin-treated
+∞
8.5
8
*
A03FA01, ,
ATC
metoclopramide; systemic, rectal
+∞
8.5
8
*
A06AC01, ,
ATC
ispaghula (psylla seeds); oral
+∞
8.5
8
*
H907, ,
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
+∞
8.5
8
*
ZXD20, ,
ICD-O-3
+∞
8.5
8
*
WZC10, ,
ICD-O-3
+∞
8.5
8
*
J010, ,
ICD-O-3
+∞
8.5
8
*
7442B, ,
ICD-9 Finland
Congenital anomalies of ear, face and neck, Other specified anomalies of ear[MICROTIA]
+∞
8.5
8
*
L11, ,
ICD-O-3
+∞
8.5
8
*
N06AB04, ,
ATC
citalopram; systemic
+∞
8.5
8
*
R03BA05, ,
ATC
fluticasone; inhalant
+∞
8.5
8
*
H906, ,
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
+∞
8.5
8
*
Z315, ,
ICD-10 Finland
Genetic counselling
+∞
8.5
8
*
F329, ,
ICD-10 Finland
Depressive episode, unspecified
+∞
8.5
8
*
D11, ,
ICD-O-3
+∞
8.5
8
*
O800, ,
ICD-10 Finland
Spontaneous vertex delivery
+∞
8.5
8
*
H03AA01, ,
ATC
levothyroxine sodium; systemic
+∞
8.5
8
*
OAB44, ,
ICD-O-3
+∞
8.5
8
*
K0522, ,
ICD-O-3
+∞
8.5
8
*
SPAT1386, ,
ICD-O-3
+∞
8.5
8
*
M796, ,
ICD-10 Finland
Pain in limb
+∞
8.5
8
*
Z258, ,
ICD-O-3
+∞
8.5
8
*
103, ,
Kela drug reimbursment
Diabetes, insulin-treated
+∞
8.5
8
*
ZXE11, ,
ICD-O-3
+∞
8.5
8
*
SJD20, ,
ICD-O-3
+∞
8.5
8
*
B02AA02, ,
ATC
tranexamic acid; systemic
+∞
8.5
8
*
C09CA06, ,
ATC
candesartan; oral
+∞
8.5
8
*
SHB00, ,
ICD-O-3
+∞
8.5
8
*
L02, ,
ICD-O-3
+∞
8.5
8
*
H109, ,
ICD-O-3
+∞
8.5
8
*
N06AB06, ,
ATC
sertraline; oral
+∞
8.5
8
*
OAA41, ,
ICD-O-3
+∞
8.5
8
*
D01AC20, ,
ATC
imidazoles/triazoles in combination with corticosteroids; topical
+∞
8.5
8
*
N03AX16, ,
ATC
[U] pregabalin
+∞
8.5
8
*
Z004, ,
ICD-10 Finland
General psychiatric examination, not elsewhere classified
+∞
8.5
8
*
L15, ,
ICD-O-3
+∞
8.5
8
*
J01FA06, ,
ATC
roxithromycin; oral
+∞
8.5
8
*
OAA11, ,
ICD-O-3
+∞
8.5
8
*
Q670, ,
ICD-10 Finland
Facial asymmetry
+∞
8.5
8
*
A09, ,
ICD-O-3
+∞
8.5
8
*
R074, ,
ICD-10 Finland
Chest pain, unspecified
+∞
7.4
7
*
R103, ,
ICD-O-3
+∞
7.4
7
*
M01AC06, ,
ATC
meloxicam; systemic, rectal
+∞
7.4
7
*
C09AA05, ,
ATC
ramipril; oral
+∞
7.4
7
*
F3210, ,
ICD-10 Finland
Moderate depressive episode without somatic syndrome
+∞
7.4
7
*
R238, ,
ICD-O-3
+∞
7.4
7
*
C07AB07, ,
ATC
bisoprolol; oral
+∞
7.4
7
*
K021, ,
ICD-10 Finland
Caries of dentine
+∞
7.4
7
*
M02AA07, ,
ATC
piroxicam; topical
+∞
7.4
7
*
SHA01, ,
ICD-O-3
+∞
7.4
7
*
H29, ,
ICD-O-3
+∞
7.4
7
*
H01, ,
ICD-O-3
+∞
7.4
7
*
SJX10, ,
ICD-O-3
+∞
7.4
7
*
R01BA52, ,
ATC
pseudoephedrine, combinations; oral
+∞
7.4
7
*
TPH07, ,
ICD-O-3
+∞
7.4
7
*
Q8703, ,
ICD-10 Finland
Syndrome Goldenhar
+∞
7.4
7
*
SCA02, ,
ICD-O-3
+∞
7.4
7
*
MAX99, ,
ICD-O-3
+∞
7.4
7
*
X23, ,
ICD-O-3
+∞
7.4
7
*
J350, ,
ICD-10 Finland
Chronic tonsillitis
+∞
7.4
7
*
H653, ,
ICD-10 Finland
Chronic mucoid otitis media
+∞
7.4
7
*
J01AA04, ,
ATC
lymecycline; systemic
+∞
7.4
7
*
Z712, ,
ICD-10 Finland
Person consulting for explanation of investigation findings
+∞
7.4
7
*
SGA01, ,
ICD-O-3
+∞
7.4
7
*
A02BC03, ,
ATC
lansoprazole; oral
+∞
7.4
7
*
R2130, ,
ICD-O-3
+∞
7.4
7
*
Z304, ,
ICD-O-3
+∞
7.4
7
*
K045, ,
ICD-O-3
+∞
7.4
7
*
SAB01, ,
ICD-O-3
+∞
7.4
7
*
C09CA01, ,
ATC
losartan; oral
+∞
7.4
7
*
H02AB04, ,
ATC
methylprednisolone; systemic
+∞
7.4
7
*
D01BA02, ,
ATC
terbinafine; oral
+∞
7.4
7
*
WZC30, ,
ICD-O-3
+∞
7.4
7
*
ZXE13, ,
ICD-O-3
+∞
7.4
7
*
M545, ,
ICD-10 Finland
Low back pain
+∞
7.4
7
*
SJC40, ,
ICD-O-3
+∞
7.4
7
*
SJD40, ,
ICD-O-3
+∞
7.4
7
*
M255, ,
ICD-10 Finland
Pain in joint
+∞
7.4
7
*
WYA50, ,
ICD-O-3
+∞
7.4
7
*
SJC02, ,
ICD-O-3
+∞
7.4
7
*
SPAT1324, ,
ICD-O-3
+∞
7.4
7
*
D07AC13, ,
ATC
mometasone; topical
+∞
7.4
7
*
TLC00, ,
ICD-O-3
+∞
7.4
7
*
SPAT1366, ,
ICD-O-3
+∞
7.4
7
*
N05AH03, ,
ATC
olanzapine; systemic
+∞
7.4
7
*
L29, ,
ICD-O-3
+∞
7.4
7
*
IEY05, ,
ICD-O-3
+∞
7.4
7
*
ZXE40, ,
ICD-O-3
+∞
7.4
7
*
D07BC01, ,
ATC
betamethasone and antiseptics; topical
+∞
7.4
7
*
R03AK07, ,
ATC
formoterol and budesonide; inhalant
+∞
7.4
7
*
C10AA01, ,
ATC
simvastatin; oral
+∞
7.4
7
*
Q172, ,
ICD-O-3
+∞
7.4
7
*
N300, ,
ICD-O-3
+∞
7.4
7
*
R074, ,
ICD-O-3
+∞
7.4
7
*
S03CA04, ,
ATC
hydrocortisone and antiinfectives; ophthalmic, otic
+∞
6.3
6
*
N05AX12, ,
ATC
aripiprazole; systemic
+∞
6.3
6
*
C10AA05, ,
ATC
atorvastatin; oral
+∞
6.3
6
*
Z461, ,
ICD-10 Finland
Fitting and adjustment of hearing aid
+∞
6.3
6
*
J459, ,
ICD-O-3
+∞
6.3
6
*
H10, ,
ICD-O-3
+∞
6.3
6
*
R03DC03, ,
ATC
montelukast; oral
+∞
6.3
6
*
WX882, ,
ICD-O-3
+∞
6.3
6
*
SAB02, ,
ICD-O-3
+∞
6.3
6
*
E000002, ,
ATC
+∞
6.3
6
*
F419, ,
ICD-O-3
+∞
6.3
6
*
Z108, ,
ICD-O-3
+∞
6.3
6
*
D07CA01, ,
ATC
hydrocortisone and antibiotics; topical
+∞
6.3
6
*
A05, ,
ICD-O-3
+∞
6.3
6
*
Z024, ,
ICD-O-3
+∞
6.3
6
*
F02, ,
ICD-O-3
+∞
6.3
6
*
H02, ,
ICD-O-3
+∞
6.3
6
*
Z023, ,
ICD-O-3
+∞
6.3
6
*
C03CA01, ,
ATC
furosemide; systemic
+∞
6.3
6
*
C08CA01, ,
ATC
amlodipine; oral
+∞
6.3
6
*
SPAT1385, ,
ICD-O-3
+∞
6.3
6
*
L84, ,
ICD-O-3
+∞
6.3
6
*
L14, ,
ICD-O-3
+∞
6.3
6
*
XA800, ,
ICD-O-3
+∞
6.3
6
*
WX105, ,
ICD-O-3
+∞
6.3
6
*
Z003, ,
ICD-O-3
+∞
6.3
6
*
SGB30, ,
ICD-O-3
+∞
6.3
6
*
H530, ,
ICD-10 Finland
Amblyopia ex anopsia
+∞
6.3
6
*
R103, ,
ICD-10 Finland
Pain localized to other parts of lower abdomen
+∞
6.3
6
*
MA2HE, ,
ICD-O-3
+∞
6.3
6
*
Z0389, ,
ICD-10 Finland
Observation for other suspected diseases and conditions
+∞
6.3
6
*
K0366, ,
ICD-O-3
+∞
6.3
6
*
G03CA03, ,
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
+∞
6.3
6
*
G473, ,
ICD-O-3
+∞
6.3
6
*
EMB10, ,
ICD-O-3
+∞
6.3
6
*
ZXE06, ,
ICD-O-3
+∞
6.3
6
*
J039, ,
ICD-10 Finland
Acute tonsillitis, unspecified
+∞
6.3
6
*
ZXE02, ,
ICD-O-3
+∞
6.3
6
*
H669, ,
ICD-O-3
+∞
6.3
6
*
IGY02, ,
ICD-O-3
+∞
6.3
6
*
SGA03, ,
ICD-O-3
+∞
6.3
6
*
TEW99, ,
ICD-O-3
+∞
6.3
6
*
K0880, ,
ICD-O-3
+∞
6.3
6
*
WZC05, ,
ICD-O-3
+∞
6.3
6
*
Z348, ,
ICD-10 Finland
Supervision of other normal pregnancy
+∞
6.3
6
*
D06AX01, ,
ATC
fusidic acid; topical
+∞
6.3
6
*
ZXD30, ,
ICD-O-3
+∞
6.3
6
*
R42, ,
ICD-O-3
+∞
6.3
6
*
C05AA08, ,
ATC
fluocortolone; rectal, topical
+∞
6.3
6
*
MA3AE, ,
ICD-O-3
+∞
6.3
6
*
JN1AE, ,
ICD-O-3
+∞
6.3
6
*
EBA12, ,
ICD-O-3
+∞
6.3
6
*
Z017, ,
ICD-O-3
+∞
6.3
6
*
N06AX16, ,
ATC
venlafaxine; oral
+∞
6.3
6
*
4105, ,
ICD-O-3
+∞
6.3
6
*
S21, ,
ICD-O-3
+∞
6.3
6
*
Z018, ,
ICD-O-3
+∞
6.3
6
*
MA5AE, ,
ICD-O-3
+∞
6.3
6
*
OAB39, ,
ICD-O-3
+∞
6.3
6
*
SAB03, ,
ICD-O-3
+∞
6.3
6
*
XX9AW, ,
ICD-O-3
+∞
6.3
6
*
K051, ,
ICD-O-3
+∞
6.3
6
*
A02BC01, ,
ATC
omeprazole; systemic
+∞
6.3
6
*
R4130, ,
ICD-O-3
+∞
6.3
6
*
SPAT1240, ,
ICD-O-3
+∞
6.3
6
*
SFA00, ,
ICD-O-3
+∞
6.3
6
*
J02AC02, ,
ATC
itraconazole; systemic
+∞
6.3
6
*
P06, ,
ICD-O-3
+∞
6.3
6
*
SJC01, ,
ICD-O-3
+∞
6.3
6
*
SJX21, ,
ICD-O-3
+∞
6.3
6
*
Z016, ,
ICD-O-3
+∞
6.3
6
*
WX700, ,
ICD-O-3
+∞
6.3
6
*
F322, ,
ICD-10 Finland
Severe depressive episode without psychotic symptoms
+∞
6.3
6
*
F03, ,
ICD-O-3
+∞
6.3
6
*
K02, ,
ICD-O-3
+∞
6.3
6
*
SJC03, ,
ICD-O-3
+∞
6.3
6
*
OAA10, ,
ICD-O-3
+∞
6.3
6
*
J342, ,
ICD-10 Finland
Deviated nasal septum
+∞
6.3
6
*
SPAT1197, ,
ICD-O-3
+∞
6.3
6
*
H13, ,
ICD-O-3
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
20
117
2.00
1.69
1.9
3.4
—
—
—
0
0
0
44
0.00
1.58
0.0
2.0
—
—
—
0
0
36
274
1.67
1.23
3.7
8.4
6.75
6.31
mmol/l
0.37
30
247
6
26
2.43
1.21
1.5
3.3
—
—
—
0
0
5
20
2.61
1.17
2.2
6.7
0.94
1.62
%
—
5
20
7
37
1.99
0.97
4.3
12.5
106.14
103.92
mmol/l
—
7
37
31
241
1.53
0.90
2.7
3.5
—
—
—
0
0
8
47
1.79
0.84
2.8
14.1
25.51
25.18
mmol/l
—
8
47
50
439
1.52
0.75
6.2
8.6
100.49
100.11
ml/min/173m2
0.03
38
337
20
147
1.51
0.73
2.0
1.6
103.54
95.50
pmol/l
0.44
13
73
10
63
1.69
0.66
2.4
1.7
366.60
504.67
pmol/l
—
10
58
13
89
1.57
0.64
1.6
1.4
21.08
19.79
nmol/l
0.12
13
79
0
20
0.00
0.61
0.0
1.1
—
—
—
0
0
0
21
0.00
0.61
0.0
1.1
—
—
—
0
0
0
21
0.00
0.61
0.0
1.4
—
—
—
0
0
0
22
0.00
0.60
0.0
1.6
—
—
—
0
0
7
105
0.63
0.54
2.1
2.0
—
—
—
0
0
7
46
1.58
0.50
1.3
1.5
—
—
—
0
0
7
46
1.58
0.50
1.3
1.5
—
—
—
0
0
7
46
1.58
0.50
1.3
1.5
—
—
—
0
0
58
544
1.45
0.43
6.8
11.9
20.86
20.52
mg/l
0.02
42
392
0
15
0.00
0.42
0.0
1.3
—
—
—
0
0
0
15
0.00
0.42
0.0
1.9
—
—
—
0
0
0
15
0.00
0.42
0.0
1.6
—
—
—
0
0
0
16
0.00
0.41
0.0
3.3
—
—
—
0
0
0
17
0.00
0.41
0.0
1.2
—
5.00
—
0
9
0
18
0.00
0.40
0.0
1.2
—
1.78
—
0
9
10
133
0.71
0.38
2.0
3.2
44.90
55.64
u/l
—
10
125
17
206
0.77
0.36
1.4
3.3
—
—
—
0
0
7
53
1.36
0.32
1.4
1.5
—
—
—
0
0
32
285
1.23
0.31
2.7
2.9
49.41
64.44
ug/l
0.77
32
264
24
207
1.25
0.31
1.5
1.7
—
—
—
0
0
35
381
0.83
0.26
2.9
4.0
8.66
8.23
mm/h
0.06
35
357
10
123
0.78
0.22
2.7
2.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
2.1
—
10.08
—
0
11
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
3.8
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
3.9
—
6.90
—
0
10
0
12
0.00
0.21
0.0
1.3
—
283.33
—
0
12
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.8
—
—
—
0
0
6
52
1.17
0.19
1.0
1.2
—
—
—
0
0
7
60
1.19
0.18
4.1
5.5
330.71
672.76
ng/l
—
7
47
5
67
0.73
0.18
1.0
1.8
—
—
—
0
0
16
174
0.89
0.09
1.8
4.0
—
—
—
0
0
6
74
0.79
0.08
14.7
13.2
1.23
1.20
mmol/l
—
6
68
17
177
0.95
0.01
3.4
2.5
—
—
—
0
0
53
536
0.95
0.00
4.3
3.9
—
—
—
0
0
19
194
0.97
0.00
3.3
2.7
—
—
—
0
0
32
318
1.01
0.00
4.8
10.2
3.73
3.85
e9/l
0.09
27
283
0
7
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.5
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
0.00
—
0
9
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
5.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
0.00
—
0
9
0
9
0.00
-0.00
0.0
1.0
—
0.00
—
0
9
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
7.78
—
0
9
0
9
0.00
-0.00
0.0
1.0
—
2.90
—
0
9
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
38.52
—
0
9
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
9.59
—
0
9
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
5.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
9
92
0.97
-0.00
1.3
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
0.00
—
0
9
0
9
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
6
0.00
-0.00
0.0
6.8
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
3.66
—
0
9
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
6.0
—
42.52
—
0
5
0
5
0.00
-0.00
0.0
1.8
—
0.19
—
0
5
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
5.70
—
0
5
0
5
0.00
-0.00
0.0
8.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
4.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: Q17_MICROTIA – Microtia (small ears)
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).